{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:07:31Z","timestamp":1766441251962},"publisher-location":"Chichester, UK","reference-count":46,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003474","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T17:14:00Z","timestamp":1069434840000},"source":"Crossref","is-referenced-by-count":42,"title":["Bisphosphonates for breast cancer"],"prefix":"10.1002","author":[{"given":"N","family":"Pavlakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,21]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD003474-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","article-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate","volume":"16","author":"Hortobagyi","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"24","key":"10.1002\/14651858.CD003474-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003474-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003474-BIB4|cit4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial","volume":"17","author":"Theriault","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003474-BIB5|cit5","series-title":"Proc Annu Meet Am Soc Clin Oncol","first-page":"abstract 2222","article-title":"Double-blind Placebo-Controlled Trial of Intravenous Ibandronate in Breast Cancer Metastatic to Bone","author":"Body","year":"1999"},{"key":"10.1002\/14651858.CD003474-BIB6|cit6","series-title":"Proc Eur Com Clin Onc","first-page":"Abstract 269","article-title":"Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate","author":"Diel","year":"1999"},{"issue":"Supp .7","key":"10.1002\/14651858.CD003474-BIB7|cit7","first-page":"S41","article-title":"Delayed progression of bone metastases with pamodronate therapy in breast cancer patients: A randomized , multicenter phase III trial","volume":"5","author":"Conte","year":"1994","journal-title":"Annals of Oncology"},{"issue":"9","key":"10.1002\/14651858.CD003474-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.1996.14.9.2552","article-title":"Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: Results from a multinational randomized controlled trial","volume":"14","author":"Conte","year":"1996","journal-title":"Jounal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD003474-BIB9|cit9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199808063390601","article-title":"Reduction in new metastases in breast cancer with adjuvant clodronate treatment","volume":"339","author":"Diel","year":"1998","journal-title":"The New England Journal Of Medicine"},{"key":"10.1002\/14651858.CD003474-BIB10|cit10","series-title":"Proc Annu Meet Am Soc Clin Oncol","first-page":"Abstract 488","article-title":"Continual oral versus intravenous interval therapy with bisphosphonates in patients with breast cancer and bone metastases","author":"Diel","year":"1999"},{"key":"10.1002\/14651858.CD003474-BIB11|cit11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(83)92755-1","article-title":"Long-term controlled trial with diphosphonate in aptients with osteolytic bone metastases","volume":"1","author":"Elomaa","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003474-BIB12|cit12","first-page":"111","article-title":"Clodronate for osteolytic metastases due to breast cancer","volume":"42","author":"Elomaa","year":"1988","journal-title":"Biomed. & Parmacother"},{"issue":"Supp 1","key":"10.1002\/14651858.CD003474-BIB13|cit13","first-page":"S53","article-title":"Treatment of skeletal disease in breast cancer: A controlled clodronate trial","volume":"8","author":"Elomma","year":"1987","journal-title":"Bone"},{"key":"10.1002\/14651858.CD003474-BIB14|cit14","first-page":"3383","article-title":"Efficacy of pamidronate in breast cancer with bone metastases: A randomized , double-blind placebo-controlled multicenter study","volume":"19","author":"Hultborn","year":"1999","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD003474-BIB15|cit15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S8756-3282(96)00285-2","article-title":"Clodronate decreases the frequency of skeletal metastases in women with breast cancer","volume":"19","author":"Kanis","year":"1996","journal-title":"Bone"},{"key":"10.1002\/14651858.CD003474-BIB16|cit16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.1999.00507.x","article-title":"Oral clodronate in breast cancer patients with bone metastases: a randomized study","volume":"246","author":"Kristensen","year":"1999","journal-title":"Jounal of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003474-BIB17|cit17","first-page":"177","article-title":"Adjuvant clodronate therapy in patients with locally advanced breast cancer - long term results of a double blind randomized trial","volume":"47","author":"Mardiak","year":"2000","journal-title":"Neoplasma"},{"key":"10.1002\/14651858.CD003474-BIB18|cit18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000226904","article-title":"Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton","volume":"48","author":"Martoni","year":"1991","journal-title":"Oncology"},{"key":"10.1002\/14651858.CD003474-BIB19|cit19","unstructured":"Paterson AHG Kanis JA Powles TJ McCloskey EV Archabault WT Kurman MR A reanalysis of a trial of clodronate in patients with breast cancer and bone metastases To be submitted for publication 2001"},{"issue":"1","key":"10.1002\/14651858.CD003474-BIB20|cit20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.1993.11.1.59","article-title":"Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer","volume":"11","author":"Paterson","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003474-BIB21|cit21","series-title":"Proc Annu Meet Am Soc Clin Oncol","first-page":"Abstract 468","article-title":"Adjuvant clodronate reduces the incidence of bone metastases in patients with primary operable breast cancer","author":"Powles","year":"1998"},{"issue":"5","key":"10.1002\/14651858.CD003474-BIB22|cit22","first-page":"377","article-title":"Zolendronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or psteolytic lesions of multiple myeloma: A Phase III, bouble-blind, comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"The Cancer journal"},{"issue":"1","key":"10.1002\/14651858.CD003474-BIB23|cit23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1200\/JCO.2001.19.1.10","article-title":"Adjuvant clodronate treatment does not reduce the frquency of skeltal metastases in node-postive breast cancer patients: 5 year results of a randomized controlled study","volume":"19","author":"Saarto","year":"2001","journal-title":"JOurnal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD003474-BIB24|cit24","first-page":"701","article-title":"Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases","volume":"88","author":"Tubiana-Hulin","year":"2001","journal-title":"Bulletin du Cancer"},{"key":"10.1002\/14651858.CD003474-BIB25|cit25","first-page":"73","article-title":"Effect of long-term bisphosponate treatment on morbidity due to bone metastases in breast cancer patients","volume-title":"Recent results in Cancer Research","volume":"116","author":"Cleton","year":"1989"},{"issue":"3","key":"10.1002\/14651858.CD003474-BIB26|cit26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1993.11.3.491","article-title":"Palliative pamidronate treatment in patients with bone metastases from breast cancer","volume":"11","author":"Holten-Vaerzantvoort","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003474-BIB27|cit27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(87)92555-4","article-title":"Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphophonate (APD) treatment","volume":"ii","author":"Holten-Verzantvoort","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003474-BIB28|cit28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0277-5379(91)90212-V","article-title":"The effect of Supportive Pamidronate Treatment on Aspects of Quality of Life of Patients with Advanced Breast Cancer","volume":"27","author":"Holten-Verzantvoort","year":"1991","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003474-BIB29|cit29","first-page":"450","article-title":"Does supportive pamidronate treatment prevent or delay the first manifestations of bone metastases in breast cancer patients?","volume":"32A","author":"van","year":"1996","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD003474-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0","article-title":"Zolendronic Acid Reduces Skeleta-Related Events in Patients with Osteolytic Metastases: A double-blind, randomized dose-response study","volume":"91","author":"Berenson","year":"2001","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD003474-BIB31|cit31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-9343(83)90958-0","article-title":"Effects if dichloromethylene Diphosphonate in Women with Breast Carcinoma Metastatic to the Skeleton","volume":"74","author":"Siris","year":"1983","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD003474-BIB32|cit32","unstructured":"Phase III Randomized study of Adjuvant clodronate with or without systemic chemotherapy and\/or tamoxifen in women with early-stage Breast Cancer Ongoing study 2001"},{"issue":"3","key":"10.1002\/14651858.CD003474-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1998.16.3.1218","article-title":"Should bisphosphonates be part of the standard therapy of patients with mutliple myeloma or bone metastases from other cancers? An evidence-based review","volume":"16","author":"Bloomfield","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD003474-BIB34|cit34","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.1998.16.12.3890","article-title":"Current use of bisphosphonates in oncology","volume":"16","author":"Body","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003474-BIB35|cit35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0305-7372(85)90008-8","article-title":"Bone metastases and breast cancer","volume":"12","author":"Coleman","year":"1985","journal-title":"Cancer Treatment Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003474-BIB36|cit36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"British Journal of Cancer"},{"issue":"23","key":"10.1002\/14651858.CD003474-BIB37|cit37","first-page":"3295","article-title":"Identifying breast cancer patients at high risk for bone metastases","volume":"18","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD003474-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1646::AID-CNCR14>3.0.CO;2-#","article-title":"Issue concerning the role of chemotherapy and hormonal therapy of bone metastases from breast cancer","volume":"80","author":"Harvey","year":"1997","journal-title":"Cancer"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003474-BIB39|cit39","doi-asserted-by":"crossref","first-page":"101S","DOI":"10.1016\/8756-3282(95)00194-I","article-title":"Bone and cancer: pathophysiology and treatment of metastases","volume":"17","author":"Kanis","year":"1995","journal-title":"Bone"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003474-BIB40|cit40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/8756-3282(91)90057-P","article-title":"Mechanisms of osteolytic bone destruction","volume":"12","author":"Mundy","year":"1991","journal-title":"Bone"},{"issue":"8","key":"10.1002\/14651858.CD003474-BIB41|cit41","first-page":"1546","article-title":"Mechanisms of bone metastases","volume":"80","author":"Mundy","year":"1987","journal-title":"Cancer"},{"issue":"8","key":"10.1002\/14651858.CD003474-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z","article-title":"Overview of bisphosphonates","volume":"80","author":"Rogers","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003474-BIB43|cit43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1002\/14651858.CD003474-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/1097-0142(19861215)58:12<2589::AID-CNCR2820581206>3.0.CO;2-O","article-title":"Clinical course of breast cancer patients with osseous metastases treated with combination chemotherapy","volume":"58","author":"Scheid","year":"1986","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD003474-BIB45|cit45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/ctrv.1999.0161","article-title":"Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer","volume":"26","author":"Stockler","year":"2000","journal-title":"Cancer Treatment Reviews"},{"key":"10.1002\/14651858.CD003474-BIB46|cit46","unstructured":"WHO The International Agency for Research on Cancer www.who.org - World Health Organisation web site 1998"}],"container-title":["The Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003474\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:21:12Z","timestamp":1628529672000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,21]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003474","relation":{},"subject":[],"published":{"date-parts":[[2002,1,21]]}}}